Pacira BioSciences: Peers

The FY2023 (Dec) proxy of Pacira BioSciences names 20 peer companies for pay. Among Pacira BioSciences and these peers, CEO pay was 8th highest of 9 and total shareholder return was 6th highest of 9.

8th highest of 9in Pacira BioSciences and its pay peers, FY2023 (Dec) by CEO pay:

$3.1M$17.0M

6th highest of 9in Pacira BioSciences and its pay peers, FY2023 (Dec) by total shareholder return:

$56$250

Pay peer group, FY2023 (Dec) proxy

United Therapeutics
Ultragenyx Pharmaceutical
Ionis Pharmaceuticals
Halozyme Therapeutics
Alkermes plc.
PTC Therapeutics
Travere Therapeutics
CareDx
Acadia PharmaceuticalsNot disclosedNot disclosed
Amicus Therapeutics, Inc.Not disclosedNot disclosed
Blueprint Medicines CorporationNot disclosedNot disclosed
Corcept TherapeuticsNot disclosedNot disclosed
Dynavax Technologies Corporation [img:ic_plus-pn]Not disclosedNot disclosed
Emergent BioSolutions, Inc.Not disclosedNot disclosed
ExelixisNot disclosedNot disclosed
Ironwood Pharmaceuticals, Inc.Not disclosedNot disclosed
Natera, Inc. [img:ic_plus-pn]Not disclosedNot disclosed
Organogenesis Holdings, Inc.Not disclosedNot disclosed
Sarepta Therapeutics, Inc. [img:ic_plus-pn]Not disclosedNot disclosed
Supernus PharmaceuticalsNot disclosedNot disclosed
20 companies

PSU comparator group

The companies that relative total shareholder return is measured against for performance stock units.

S&P Pharmaceuticals Select Industry Index (index)Not disclosedNot disclosed
1 company

Changes by year

FY2024 (Dec) proxy

  • AddedAni Pharmaceuticalspay peer groupdue to their revenues and market capitalization now falling significantly outside the peer group criteria
  • RemovedEmergent BioSolutions, Inc.pay peer groupdue to their revenues and market capitalization now falling significantly outside the peer group criteria

FY2023 (Dec) proxy

  • AddedDynavax Technologies Corporationpay peer groupdue to their revenues or market capitalization now falling significantly outside the peer group criteria
  • AddedNaterapay peer groupdue to their revenues or market capitalization now falling significantly outside the peer group criteria
  • AddedSarepta Therapeuticspay peer groupdue to their revenues or market capitalization now falling significantly outside the peer group criteria
  • RemovedAgios Pharmaceuticalspay peer groupdue to their revenues or market capitalization now falling significantly outside the peer group criteria
  • RemovedCoherus BioSciences, Inc.pay peer groupdue to their revenues or market capitalization now falling significantly outside the peer group criteria
  • RemovedCollegium Pharmaceuticalpay peer groupdue to their revenues or market capitalization now falling significantly outside the peer group criteria

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.